Jiangsu Hengrui Medicine
600276.SS
#475
Rank
โ‚น4.999 T
Marketcap
โ‚น753.19
Share price
-0.54%
Change (1 day)
20.07%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

EPS for Jiangsu Hengrui Medicine (600276.SS)

EPS in 2026 (TTM): โ‚น12.84

According to Jiangsu Hengrui Medicine 's latest financial reports the company's current EPS (TTM) is โ‚น14.06. In 2025 the company made an earnings per share (EPS) of โ‚น16.22 an increase over its 2024 EPS that were of โ‚น13.07.

EPS history for Jiangsu Hengrui Medicine from 2000 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น12.84-20.85%
2025โ‚น16.2224.14%
2024โ‚น13.0742.43%
2023โ‚น9.188.77%
2022โ‚น8.44-20.62%
2021โ‚น10.63-26.59%
2020โ‚น14.4827.24%
2019โ‚น11.3828.41%
2018โ‚น8.8620.04%
2017โ‚น7.3831.21%
2016โ‚น5.6311.46%
2015โ‚น5.0536.27%
2014โ‚น3.7019.77%
2013โ‚น3.0918.05%
2012โ‚น2.6223.9%
2011โ‚น2.1126.9%
2010โ‚น1.6712.37%
2009โ‚น1.4856.6%
2008โ‚น0.959.18%
2007โ‚น0.87114.48%
2006โ‚น0.4064.83%
2005โ‚น0.2535.55%
2004โ‚น0.1829.73%
2003โ‚น0.1419.86%
2002โ‚น0.12-2.71%
2001โ‚น0.121.02%
2000โ‚น0.12